Perfusion Systems Market – Which application market will dominate in future?

The perfusion systems market is projected to reach USD 1,198.8 million by 2021 from USD 989.4 million in 2016, at a CAGR of 3.9% from 2016 to 2021.

On the basis of application, the perfusion systems market is segmented into cardiopulmonary perfusion systems, cell perfusion systems, and ex vivo organ perfusion. The cardiopulmonary perfusion systems segment accounted for the largest share of the global perfusion systems market in 2016. The large share of this segment can be attributed to the increasing prevalence of cardiovascular & respiratory diseases and the increasing number of organ transplant procedures, worldwide.

Market Dynamics

Drivers

• Increasing prevalence of cardiovascular and respiratory diseases
• Rising number of organ transplantations
• Growth in Aging Population, Increasing Incidence of Multiple Organ Failures
• Government and NGO Initiatives to Encourage Organ Donation
• Increasing Investments in Cell-Based Research
• Increase in Biologic Manufacturing

Restraints

• High Cost of Organ Transplantation
• Ethical Concerns and High Cost of Cell-Based Research

Opportunities

• Increasing Pharmaceutical Research in Emerging Markets
• Rising Preference for Continuous Manufacturing

Challenges

• Organ Supply-Demand Gap